enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Roche joins race for obesity drugs with $2.7 billion Carmot deal

    www.aol.com/news/roche-enters-obesity-drug...

    Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk ...

  3. Roche targets more than $3 billion in annual obesity sales - AOL

    www.aol.com/news/roche-targets-more-3-billion...

    Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics have the combined potential of more than 3 billion Swiss francs ($3.6 ...

  4. Roche - Wikipedia

    en.wikipedia.org/wiki/Roche

    F. Hoffmann-La Roche AG, commonly known as Roche (/ r ɒ ʃ /), is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company , Roche Holding AG , has shares listed on the SIX Swiss Exchange .

  5. Roche to fast-track weight loss drugs to compete with rivals ...

    www.aol.com/news/roche-fast-track-weight-loss...

    Roche is among a growing number of would-be rivals to Novo and Eli Lilly, whose weight-loss injections have been in feverish demand, with experts boosting their sales forecasts for such treatments ...

  6. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]

  7. GTCR - Wikipedia

    en.wikipedia.org/wiki/GTCR

    GTCR logo in use prior to 1998 separation. The company was founded in 1980 as Golder Thoma & Co. by Stanley Golder, Carl Thoma, and Bryan Cressey. [2] In the 1970s, Golder built the private equity program at First Chicago Corp. [3] where he is noted primarily for backing Federal Express and for efforts as chairman of the National Venture Capital Association and the National Association of ...

  8. Roche shares knocked by concern over side effects in obesity ...

    www.aol.com/news/roche-shares-drop-side-effects...

    Side effects from the pill, part of Roche's $2.7 billion acquisition of Carmot in December, were mostly gastrointestinal (GI), like those associated with similar drugs.

  9. RecycLiCo Battery Materials Engages Carmot Strategic Group ...

    lite.aol.com/tech/story/0022/20250128/9348456.htm

    SURREY, British Columbia, Jan. 28, 2025 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”), (TSX.V: AMY | OTCQB: AMYZF| FSE: ID4), a pioneer in the field of lithium-ion battery recycling technology, is pleased to announce that it has engaged Penney Capital and Carmot Strategic Group, Inc. to assist in the company’s efforts to identify, and qualify for ...